KURA vs PODD · rev $20.9M vs P/E 34, rev $2.71B
Kura Oncology Inc (KURA) versus Insulet Corporation (PODD) — a side-by-side from cached financials, not a winner call.
Kura Oncology Inc (KURA) is a biotechnology company listed on NASDAQ.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
Latest reported KURA revenue for 2026-06-30 was $20.9M. Net income was -$68.3M. Revenue was up 14.3% from 2026-03-31 to 2026-06-30. KURA currently screens at market cap $861.1M.
Latest reported PODD revenue for 2025-12-31 was $2.71B. Net income was $247.1M. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
KURA currently screens at market cap $861.1M. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Not investment advice. Open the KURA and PODD stock pages for the full models.
Not investment advice.